Article in Allergy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
José Antonio CañasImunoallergy Laboratory, Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain.ORCID https://orcid.org/0000-0002-0460-2813
Álvaro Arranz-FraguaImunoallergy Laboratory, Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain.ORCID https://orcid.org/0009-0008-6526-5495
José Manuel Rodrigo-MuñozImunoallergy Laboratory, Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain.ORCID https://orcid.org/0000-0003-3873-4563
Daniel Rodríguez-GonzálezImunoallergy Laboratory, Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain.ORCID https://orcid.org/0009-0006-2559-1531
Antonio Serrano-SantiagoImunoallergy Laboratory, Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain.ORCID https://orcid.org/0009-0007-2931-0992
Gema Guillén-SánchezImunoallergy Laboratory, Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain.ORCID https://orcid.org/0009-0006-2490-0304
Alma Martínez FernándezImunoallergy Laboratory, Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain.ORCID https://orcid.org/0000-0002-6712-7079
Victoria Del PozoImunoallergy Laboratory, Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain.ORCID https://orcid.org/0000-0001-6228-1969
Funding
AstraZeneca FoundationCentro de Investigación Biomédica en Red (CIBER) de Enfermedades Respiratorias (CIBERES)European Regional Development FundFundación Conchita RábagoFundación de la Sociedad Española de Alergología e Inmunología Clínica 24B_02Instituto de Salud Carlos III CP23/00017Instituto de Salud Carlos III FI25/00057Instituto de Salud Carlos III PI21/00896Instituto de Salud Carlos III PI24/00024
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Differential Effects of Benralizumab and Mepolizumab on Pro-Resolving Mediators. · full record | OpenQuestion